Enoblituzumab is a humanized IgG1 kappamab monoclonal antibody that recognizes human B7-H3 protein and can be used to study solid tumors such as non-small cell lung cancer (NSCLC).
CAS Number:
[1353485-38-7]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted